Tauns Laboratories: Supplementary Material on Financial Results for the Three Months Ended September 30, 2024
Tauns Laboratories: Financial Results for the Three Months Ended September 30, 2024 (Japanese Accounting Standards)
Tauns Laboratories: Notice of participation in Triple I for Global Health (Impact Investment Initiative for Global Health)
Tauns Laboratories: Announcement of Participation in the Triple I for Global Health (Impact Investment Initiative for Global Health)
Tauns Laboratories: Announcement of Conclusion of License Agreement with First Screening Corp.
Tauns Laboratories: Notice of signing a license agreement with First Screening Co., Ltd.
Tauns Laboratories: Announcement of Acquisition of "Kurumin" Certification as a Child-Rearing Support Company
Tauns Laboratories: Notice of obtaining “Kurumin” certification as a child-rearing support company
Tauns Laboratories: Notice of Personnel Changes
Tauns Laboratories: Notice regarding personnel changes
Tauns Laboratories: Articles of Incorporation 2024/09/19
Tauns Laboratories: 2024 annual financial statements (Japanese accounting standards)
Tauns Laboratories: Announcements of global strategic capital business partnership between Towns Co., Ltd. and Connect Afya Co., Ltd.
Tauns Laboratories: Announcement of strategic capital and business partnership between TAUNS Laboratories, Inc. and Connect Afya Ltd.
Tauns Laboratories: Independent Company Executives Declaration
Tauns Laboratories: Announcements of individual stocks regarding changes in the controlling shareholders other than the parent company.
Tauns Laboratories: Announcements of individual stock's financial information related to our listing on the Tokyo Stock Exchange's Standard Market.
TAUNS Laboratories,Inc.: Bylaws as of February 28, 2023.
TAUNS Laboratories,Inc.: (Additional) Correction report for the securities report for the listing application.
TAUNS Laboratories,Inc.: Confirmation of the appropriateness of securities reports, etc. for listing applications
No Data
No Data